Regentis Biomaterials Ltd. (RGNT)
NYSE · Healthcare
Regentis Biomaterials Ltd. Total Liabilities 2023–2025
Regentis Biomaterials Ltd. annual total liabilities history from 2023 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Regentis Biomaterials Ltd. total liabilities as of December 31, 2025: 2.9M, a 93.09% decrease year-over-year.
- Regentis Biomaterials Ltd. total liabilities for 2025 were 2.9M, a 93.09% decrease from 2024.
- Regentis Biomaterials Ltd. total liabilities for 2024 were 41.6M, a 10.11% decrease from 2023.
- Regentis Biomaterials Ltd. total liabilities for 2023 were 46.3M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Regentis Biomaterials Ltd. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $3 |
| 2024 | $42 |
| 2023 | $46 |
Regentis Biomaterials Ltd. Total Liabilities — FAQ
Regentis Biomaterials Ltd. (RGNT) total liabilities over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RGNT's total liabilities history?
The chart and table above show Regentis Biomaterials Ltd.'s total liabilities by year and by quarter, including the growth rate.